ArticleFrontiers in cardiovascular medicine2026
PCSK9 inhibitors for lipid-lowering treatment in patients with atherosclerotic cardiovascular disease: a health technology assessment.
Jingjing Lan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.